• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

The Role and Rationale for Oral Options in the Treatment of Metastatic Breast Cancer

Webinar

Breast cancer oncologists explore more recent advances using oral chemotherapies to treat metastatic breast cancer.

Related Videos
Tom Kim, chief medical officer, Sound Long-Term Care Management
4 experts are featured in this series.
4 Experts are featured in this series
4 Experts are featured in this series
4 experts are featured in this series.
Related Content
Unmet health-related social needs, like housing and transportation, are associated with higher ED and inpatient use, highlighting opportunities for targeted interventions. | Image credit: @indysystem-AdobeStock.jpeg

Health-Related Social Needs Linked to Higher ED Use

December 16th 2025
Article

A new study finds patients with unmet social needs like housing or transportation face higher ED and inpatient use and that resolving these needs may reduce utilization.

Read More

Managed Care Cast

Frameworks for Advancing Health Equity: Dental Health Care Access

December 2nd 2025
Podcast

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community health in Pennsylvania.

Listen

AJMC commentary

Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy

December 16th 2025
Article

The foundation of medically integrated pharmacy includes 7 critical pillars. This commentary focuses on the benefits of 3 of those pillars: abandonment, adherence, and access/affordability.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

November 25th 2025
Podcast

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

The FDA approved the HER2-directed DXd antibody-drug conjugate, fam-trastuzumab deruxtecan-nxki, for patients with unresectable or metastatic HER2-positive breast cancer. | Image Credit: aznan - stock.adobe.com .jpeg

FDA Approves Fam-Trastuzumab Deruxtecan-Nxki for Metastatic HER2-Positive Breast Cancer

December 15th 2025
Article

The FDA approved trastuzumab deruxtecan plus pertuzumab for first-line HER2-positive metastatic breast cancer after DESTINY-Breast09 showed major PFS gains.

Read More

COVID-19 vaccine | Image credit: Leigh Prather - stock.adobe.com

COVID-19 Vaccination in Pregnant Patients Reduces Hospitalization, Preterm Birth Across Variants

December 15th 2025
Article

COVID-19 vaccination during pregnancy lowers hospitalization and preterm birth risks, providing key guidance for maternal care strategies.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.